Preferred Label : Fluticasone Propionate;

CAS number : 80474-14-2; O2GMZ0LF5W;

UNII : O2GMZ0LF5W;

InChIKey : WMWTYOKRWGGJOA-CENSZEJFSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3497032/fr/azelastine-chlorhydrate-/-fluticasone-propionate-eg-chlorhydrate-d-azelastine-/-propionate-de-fluticasone-rhinite-allergique
2024
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
rhinitis, allergic, seasonal
fluticasone, combinations
administration, intranasal
histamine H1 antagonists, non-sedating
anti-inflammatory agents
evaluation of the transparency committee
azelastine hydrochloride
Fluticasone
rhinitis, allergic, perennial
Fluticasone Propionate
azelastine

---
https://ansm.sante.fr/actualites/decision-du-05-08-2024-portant-modification-au-registre-des-groupes-hybrides-mentionne-a-larticle-l-5121-10-du-code-de-la-sante-publique
https://ansm.sante.fr/uploads/2024/08/06/20240806-registre-hybride-decision-aout-2024.pdf
2024
false
false
false
France
French
Fluticasone-Salmeterol Drug Combination
legislation, pharmacy
legislation
drug substitution
Fluticasone Propionate
drug combinations
salmeterol and fluticasone
fluticasone

---
https://www.has-sante.fr/jcms/p_3466055/fr/propionate-de-fluticasone-cipla-propionate-de-fluticasone-asthme
2023
false
false
false
France
adult
adolescent
treatment outcome
insurance, health, reimbursement
persistent asthma
administration, inhalation
fluticasone
bronchodilator agents
evaluation of the transparency committee
Fluticasone
asthma
Fluticasone Propionate

---
https://www.has-sante.fr/jcms/p_3425784/fr/propionate-de-fluticasone/salmeterol-eg-airmaster-salmeterol/propionate-de-fluticasone-asthme-et-bpco
2023
France
evaluation of the transparency committee
asthma
Fluticasone
propionate
asthma, nos
Fluticasone Propionate
Asthma
pulmonary disease, chronic obstructive
asthma
chronic obstructive lung disease, nos

---
https://www.ema.europa.eu/en/medicines/human/EPAR/bropair-spiromax
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
salmeterol and fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
adult
adolescent
asthma
administration, inhalation
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
Fluticasone

---
https://www.has-sante.fr/jcms/p_3299694/fr/propionate-de-fluticasone-salmeterol-biogaran-airmaster-salmeterol-/-propionate-de-fluticasone
2021
false
false
false
France
drug combinations
treatment outcome
insurance, health, reimbursement
Fluticasone-Salmeterol Drug Combination
administration, inhalation
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate
bronchodilator agents
glucocorticoids
adrenergic beta-2 receptor agonists
asthma
pulmonary disease, chronic obstructive
adult
adolescent
child
salmeterol and fluticasone
evaluation of the transparency committee

---
https://www.ema.europa.eu/en/medicines/human/EPAR/seffalair-spiromax
2021
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
Fluticasone-Salmeterol Drug Combination
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
salmeterol and fluticasone
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
adult
adolescent
asthma
administration, inhalation
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
Fluticasone
Fluticasone

---
https://www.has-sante.fr/jcms/p_3299652/fr/propionate-de-fluticasone/salmeterol-mylan-salmeterol-/-propionate-de-fluticasone
2021
France
evaluation of the transparency committee
propionate
Salmeterol
Fluticasone Propionate
Fluticasone-Salmeterol Drug Combination
registries

---
https://www.has-sante.fr/jcms/p_3299688/fr/propionate-de-fluticasone/salmeterol-zentiva-salmeterol-/-propionate-de-fluticasone
2021
false
false
false
France
treatment outcome
insurance, health, reimbursement
Fluticasone-Salmeterol Drug Combination
bronchodilator agents
glucocorticoids
Fluticasone Propionate
administration, inhalation
asthma
salmeterol and fluticasone
adrenergic beta-2 receptor agonists
adult
child
adolescent
Fluticasone Propionate, Salmeterol Xinafoate Drug Combination
evaluation of the transparency committee

---
https://www.has-sante.fr/portail/jcms/c_2886947/fr/affera-flutiform
2018
false
true
false
France
Fluticasone Propionate
Formoterol Fumarate
adolescent
adult
asthma
administration, inhalation
formoterol and fluticasone
adrenergic beta-2 receptor agonists
anti-inflammatory agents
bronchodilator agents
evaluation of the transparency committee
fluticasone-formoterol
androstadienes
drug combinations
ethanolamines
Fluticasone

---
https://www.ema.europa.eu/medicines/human/EPAR/Aerivio-Spiromax
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
drug approval
europe
drug interactions
pregnancy
breast feeding
salmeterol and fluticasone
pulmonary disease, chronic obstructive
asthma
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
Severe asthma (disorder)
adult
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
risk assessment
drug evaluation, preclinical
Fluticasone-Salmeterol Drug Combination
Fluticasone
Fluticasone

---
https://www.ema.europa.eu/medicines/human/EPAR/airexar-spiromax
2016
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Fluticasone-Salmeterol Drug Combination
Fluticasone Propionate
Fluticasone Propionate
drug approval
europe
drug interactions
pregnancy
breast feeding
salmeterol and fluticasone
pulmonary disease, chronic obstructive
asthma
bronchodilator agents
bronchodilator agents
glucocorticoids
glucocorticoids
Severe asthma (disorder)
adult
administration, inhalation
adrenergic beta-2 receptor agonists
adrenergic beta-2 receptor agonists
risk assessment
drug evaluation, preclinical
Fluticasone-Salmeterol Drug Combination
Fluticasone
Fluticasone

---
http://www.has-sante.fr/portail/jcms/c_2588374/fr/flixovate
http://www.has-sante.fr/portail/jcms/c_1079022/flixovate
2016
false
France
English
French
evaluation of the transparency committee
corticosteroid therapy
Fluticasone Propionate
Fluticasone
administration, cutaneous
fluticasone
dermatologic agents
anti-inflammatory agents
infant
dermatitis, atopic
treatment outcome
insurance, health, reimbursement

---
http://base-donnees-publique.medicaments.gouv.fr/extrait.php?specid=69043954
2016
false
false
false
France
French
summary of product characteristics
package leaflet
drug combinations
administration, intranasal
nasal sprays
histamine H1 antagonists, non-sedating
anti-inflammatory agents
Fluticasone Propionate
azelastine hydrochloride
fluticasone, combinations
rhinitis, allergic, seasonal
rhinitis, allergic, perennial
drug interactions
pregnancy
breast feeding
Fluticasone Propionate
azelastine hydrochloride
drug evaluation, preclinical
anti-inflammatory agents
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
Fluticasone
suspension, nos
azelastine
propionate
azelastine hydrochloride
nose, nos
Fluticasone Propionate
propionates
suspensions
azelastine hydrochloride
Fluticasone
azelastine
Fluticasone
azelastine
phthalazines
phthalazines
phthalazines

---
http://www.has-sante.fr/portail/jcms/c_1725332/fr/dymista
2014
false
true
false
France
French
drug combinations
azelastine hydrochloride
azelastine hydrochloride
administration, intranasal
nasal sprays
rhinitis, allergic, seasonal
histamine H1 antagonists, non-sedating
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
fluticasone, combinations
anti-inflammatory agents
anti-inflammatory agents
adult
adolescent
treatment outcome
child
guidelines for drug use
evaluation of the transparency committee
rhinitis, allergic, perennial
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
azelastine
azelastine
phthalazines
phthalazines
Fluticasone
Fluticasone

---
Summary Basis of Decision (SBD) for Dymista
137 mcg azelastine hydrochloride and 50 mcg fluticasone propionate per metered spray, suspension for nasal spray, intranasal
https://hpr-rps.hres.ca/reg-content/sommaire-motif-decision-detailTwo.php?lang=fr&linkID=SBD00184
2014
false
false
false
Canada
French
English
drug combinations
azelastine hydrochloride
azelastine hydrochloride
administration, intranasal
nasal sprays
rhinitis, allergic, seasonal
histamine H1 antagonists, non-sedating
histamine H1 antagonists, non-sedating
anti-allergic agents
anti-allergic agents
fluticasone, combinations
anti-inflammatory agents
anti-inflammatory agents
drug approval
canada
adult
adolescent
drug evaluation
risk assessment
treatment outcome
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
drug information
azelastine
azelastine
phthalazines
phthalazines
Fluticasone
Fluticasone

---
http://www.has-sante.fr/portail/jcms/c_1623648/fr/flutiform-iffeza-affera
http://www.has-sante.fr/portail/jcms/c_1623647/fr/flutiform-iffeza-affera-26062013-avis-ct12574
2013
false
France
French
formoterol and fluticasone
corticosteroid therapy
Fluticasone
Formoterol Fumarate
Fluticasone Propionate
evaluation of the transparency committee
drug combinations
administration, inhalation
adrenergic beta-2 receptor agonists
bronchodilator agents
anti-inflammatory agents
insurance, health, reimbursement
asthma
adult
adolescent
treatment outcome
randomized controlled trials as topic
ethanolamines
androstadienes

---
http://www.has-sante.fr/portail/display.jsp?id=c_545472
http://www.has-sante.fr/portail/jcms/c_1264444/flixonase
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-07/flixonase_20062012_ct12070.pdf
http://www.has-sante.fr/portail/jcms/c_399550/flixonase-50-g/dose-suspension-nasale-en-flacon-pulverisateur-avec-pompe-doseuse-60-doses-et-120-doses
2012
false
France
French
corticosteroid therapy
Fluticasone Propionate
Fluticasone
anti-inflammatory agents
administration, intranasal
rhinitis, allergic, perennial
anti-allergic agents
rhinitis, allergic, seasonal
adult
child
insurance, health, reimbursement
nasal polyps
fluticasone
adolescent
treatment outcome
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_538679
http://www.has-sante.fr/portail/jcms/c_1254513/flixovate
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-06/flixovate_23052012_avis_ct12041.pdf
2012
false
false
France
French
secondary prevention
corticosteroid therapy
Fluticasone Propionate
Fluticasone
dermatologic agents
ointments
administration, cutaneous
adult
child
dermatitis, atopic
insurance, health, reimbursement
dermatitis, contact
lichenoid eruptions
anti-inflammatory agents
fluticasone
infant
psoriasis
prurigo
eczema, dyshidrotic
granuloma annulare
lupus erythematosus, discoid
mycosis fungoides
dermatitis, seborrheic
insect bites and stings
evaluation of the transparency committee

---
http://www.has-sante.fr/portail/display.jsp?id=c_545438
http://www.has-sante.fr/portail/jcms/c_1313866/flixotide-et-flixotide-diskus
http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/flixotide18072012_avis_ct12079.pdf
2012
false
France
French
corticosteroid therapy
Fluticasone Propionate
Fluticasone
administration, inhalation
insurance, health, reimbursement
asthma
fluticasone
evaluation of the transparency committee
anti-inflammatory agents
bronchodilator agents

---
http://www.has-sante.fr/portail/jcms/c_1118228/flixovate-fluticasone-dermocorticoide-dactivite-forte-synthese-d-avis
2011
false
France
French
evaluation of the transparency committee
guidelines for drug use
corticosteroid therapy
Fluticasone Propionate
Fluticasone
administration, cutaneous
anti-inflammatory agents
dermatologic agents
fluticasone
insurance, health, reimbursement
infant
dermatitis, atopic
treatment outcome

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61748649
2008
false
France
French
Fluticasone Propionate
Fluticasone
administration, intranasal
fluticasone
nasal sprays
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=62933355
2008
false
France
French
Fluticasone Propionate
Fluticasone
administration, inhalation
suspensions
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=66545581
2008
false
France
French
Fluticasone Propionate
Fluticasone
administration, inhalation
suspensions
fluticasone
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=68652265
2008
false
France
French
Fluticasone Propionate
Fluticasone
administration, inhalation
suspensions
fluticasone
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=61856322
2008
false
France
French
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
Fluticasone
Fluticasone
administration, inhalation
powders
anti-inflammatory agents
bronchodilator agents
adult
child
asthma
drug approval
drug labeling
pregnancy
fluticasone
package leaflet
summary of product characteristics

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65156075
2008
false
France
French
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
administration, inhalation
powders
anti-inflammatory agents
bronchodilator agents
bronchodilator agents
anti-inflammatory agents
asthma
adult
adolescent
child
drug approval
drug labeling
pregnancy
fluticasone
package leaflet
summary of product characteristics
Fluticasone
Fluticasone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=64115257
2008
false
France
French
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
powders
anti-inflammatory agents
bronchodilator agents
asthma
drug approval
drug labeling
pregnancy
adult
adolescent
child
administration, inhalation
fluticasone
package leaflet
summary of product characteristics
Fluticasone
Fluticasone

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=67507676
2008
false
France
French
secondary prevention
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
Fluticasone
Fluticasone
emulsions
administration, cutaneous
anti-inflammatory agents
anti-inflammatory agents
dermatologic agents
skin diseases
dermatitis, atopic
dermatitis, atopic
lichenoid eruptions
dermatitis, contact
drug approval
drug labeling
pregnancy
breast feeding
fluticasone
package leaflet
summary of product characteristics

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=63872528
2008
false
France
French
Fluticasone Propionate
Fluticasone
administration, cutaneous
ointments
fluticasone
drug information

---
http://agence-prd.ansm.sante.fr/php/ecodex/extrait.php?specid=65796011
2008
false
France
French
Fluticasone Propionate
Fluticasone
ointments
administration, cutaneous
fluticasone
drug information

---
http://www.lecrat.eu/?s=Fluticasone
2007
false
France
French
Adrenocortical steroid therapy
Glucocorticoid therapy
corticosteroid therapy
Fluticasone Propionate
pregnancy
breast feeding
glucocorticoids
fluticasone
drug information
Fluticasone

---
http://www.has-sante.fr/portail/display.jsp?id=c_400918
2006
false
France
French
secondary prevention
corticosteroid therapy
Fluticasone Propionate
anti-inflammatory agents
dermatologic agents
administration, cutaneous
insurance, health, reimbursement
adult
child
emulsions
skin diseases
dermatitis, atopic
lichenoid eruptions
dermatitis, contact
dermatitis, atopic
treatment outcome
fluticasone
evaluation of the transparency committee
Fluticasone

---
http://www.has-sante.fr/portail/display.jsp?id=c_400622
2005
false
France
French
corticosteroid therapy
Fluticasone Propionate
anti-inflammatory agents
administration, intranasal
insurance, health, reimbursement
nasal polyps
adult
treatment outcome
nasal sprays
fluticasone
evaluation of the transparency committee
Fluticasone

---
http://www.has-sante.fr/portail/display.jsp?id=c_400122
2004
false
France
French
secondary prevention
corticosteroid therapy
Fluticasone Propionate
Fluticasone Propionate
anti-inflammatory agents
dermatologic agents
administration, cutaneous
ointments
dermatitis, atopic
dermatitis, atopic
adult
child
treatment outcome
anti-inflammatory agents
dermatologic agents
fluticasone
evaluation of the transparency committee
Fluticasone
Fluticasone

---
http://www.has-sante.fr/portail/display.jsp?id=c_399551
2002
false
France
French
corticosteroid therapy
Fluticasone Propionate
bronchodilator agents
insurance, health, reimbursement
asthma
adult
child
adolescent
administration, inhalation
anti-inflammatory agents
fluticasone
evaluation of the transparency committee
Fluticasone

---
http://www.has-sante.fr/portail/display.jsp?id=c_399247
2001
false
France
French
corticosteroid therapy
Fluticasone Propionate
anti-inflammatory agents
bronchodilator agents
administration, inhalation
insurance, health, reimbursement
child
asthma
fluticasone
evaluation of the transparency committee
Fluticasone

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.